Zobrazeno 1 - 10
of 6 075
pro vyhledávání: '"HIV-1 protease inhibitor"'
Autor:
Albrijawi, M. Taleb1 (AUTHOR), Alhajj, Reda1,2,3 (AUTHOR) alhajj@ucalgary.ca
Publikováno v:
PLoS ONE. 6/21/2024, Vol. 19 Issue 6, p1-30. 30p.
Autor:
M Taleb Albrijawi, Reda Alhajj
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0303597 (2024)
The battle against viral drug resistance highlights the need for innovative approaches to replace time-consuming and costly traditional methods. Deep generative models offer automation potential, especially in the fight against Human immunodeficiency
Externí odkaz:
https://doaj.org/article/1a93836e726144f1a3f8ea61103c9772
Autor:
Baassi, Mouna1 (AUTHOR), Moussaoui, Mohamed1 (AUTHOR), Soufi, Hatim1 (AUTHOR), Rajkhowa, Sanchaita2 (AUTHOR) s_rajkhowa@dibru.ac.in, Sharma, Ashwani3 (AUTHOR), Sinha, Subrata2 (AUTHOR), Belaaouad, Said1 (AUTHOR)
Publikováno v:
PLoS ONE. 4/20/2023, Vol. 17 Issue 4, p1-28. 28p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Subbaiah, Murugaiah A.M., Ramar, Thangeswaran, Subramani, Lakshumanan, Desai, Salil D., Sinha, Sarmistha, Mandlekar, Sandhya, Jenkins, Susan M., Krystal, Mark R., Subramanian, Murali, Sridhar, Srikanth, Padmanabhan, Shweta, Bhutani, Priyadeep, Arla, Rambabu, Kadow, John F., Meanwell, Nicholas A.
Publikováno v:
In European Journal of Medicinal Chemistry 1 December 2020 207
Autor:
Pekparlak, A., Tamer, Ö., Kanmazalp, S.D., Berber, N., Arslan, M., Avcı, D., Dege, N., Tarcan, E., Atalay, Y.
Publikováno v:
In Chemical Physics Letters March 2020 742
Autor:
Thongkum, Weeraya, Hadpech, Sudarat, Tawon, Yardpiroon, Cressey, Tim R., Tayapiwatana, Chatchai
Publikováno v:
In Analytica Chimica Acta 13 September 2019 1071:86-97
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mouna Baassi, Mohamed Moussaoui, Hatim Soufi, Sanchaita Rajkhowa, Ashwani Sharma, Subrata Sinha, Said Belaaouad
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0284539 (2023)
Human Immunodeficiency Virus type 1 protease (HIV-1 PR) is one of the most challenging targets of antiretroviral therapy used in the treatment of AIDS-infected people. The performance of protease inhibitors (PIs) is limited by the development of prot
Externí odkaz:
https://doaj.org/article/12a3b0e2d79442ddbc302445aab65fe4
Publikováno v:
Lontar Komputer, Vol 12, Iss 2, Pp 62-77 (2021)
Human immunodeficiency virus (HIV) is a virus that infects an immune cell and makes the patient more susceptible to infections and other diseases. HIV is also a factor that leads to acquired immune deficiency syndrome (AIDS) disease. The active targe
Externí odkaz:
https://doaj.org/article/e13fd189ff9a47ff891a8fd742955109